Articles

26 articles
Tag: pharma ✕
FDA Approves Eli Lilly's GLP-1 Pill Foundayo: Second Oral Obesity Drug Hits US Market Science
2026-04-06T14:05:44.662Z · Src: 2026-04-06T00:00:00.000Z
fdaelilillyglp1
Biogen Acquires Apellis for .6 Billion, Building Immunology Empire Business
2026-04-04T13:46:07.311Z · Src: 2026-04-04T00:00:00.000Z
biogenapellisbiotech
Eli Lilly Buys Centessa for .3 Billion in Push to Dominate Sleep Disorder Market Business
2026-04-04T13:45:49.970Z · Src: 2026-04-04T00:00:00.000Z
eli lillycentessabiotech
Biotech IPOs Raised .7 Billion in Q1 2026 — Most Since 2021 Bubble Peak Business
2026-04-04T13:45:34.632Z · Src: 2026-04-04T00:00:00.000Z
biotechipoventure capital
Patients Prefer Peptides Over Statins Exposing Deep Trust Gap in Modern Medicine Science
2026-04-04T02:30:56.372Z · Src: 2026-04-04T00:00:00.000Z
statinspeptidesbpc157
Small Biotech Drugmakers Negotiate Tariff Deals with White House as Trade War Intensifies Business
2026-04-04T02:30:54.121Z · Src: 2026-04-04T00:00:00.000Z
biotechtariffswhitehouse
Gilead HIV Prevention Breakthrough Lenacapavir Could Adopt Subscription Pricing to Expand Global Access Science
2026-04-04T02:30:47.603Z · Src: 2026-04-04T00:00:00.000Z
gileadlenacapavirhiv
Ambrosia Raises $100 Million Series B for Oral GLP-1 Obesity Pill, Entering Crowded Race Business
2026-04-04T00:42:13.170Z · Src: 2026-04-04T00:00:00.000Z
ambrosiaglp1obesity
Obesity Drugmaker Kailera Plans IPO After Raising $1B to Challenge Wegovy and Zepbound Business
2026-04-03T14:41:05.267Z · Src: 2026-04-03T00:00:00.000Z
kaileraipoobesity
Merck Strikes $838M Antibody Discovery Deal with Infinimmune as Pharma Ramps Up AI-Driven Drug Research Science
2026-04-03T14:41:00.156Z · Src: 2026-04-03T00:00:00.000Z
merckinfinimmuneantibodies
Biogen Buys Apellis for $5.6B, Building Immunology Portfolio Ahead of Key Drug Launch Business
2026-04-03T14:40:56.719Z · Src: 2026-04-03T00:00:00.000Z
biogenapellism a
Eli Lilly Acquires Centessa for $6.3B to Bolster Neuroscience Pipeline with Sleep Disorder Drugs Business
2026-04-03T14:40:53.891Z · Src: 2026-04-03T00:00:00.000Z
elilillycentessam a
Blackstone Closes Record $6.3B Life Sciences Fund, Largest Private Equity Vehicle in Sector History Business
2026-04-03T14:40:51.206Z · Src: 2026-04-03T00:00:00.000Z
blackstonelifesciencesprivateequity
How mRNA Technology Beyond COVID Vaccines Could Transform Medicine Science
2026-04-02T01:21:10.604Z · Src: 2026-04-02T00:00:00.000Z
mrnamodernabiontech
The Antibiotics Crisis: Why Drug Companies Abandoned the Drugs We Need Most Science
2026-04-01T19:10:46.605Z · Src: 2026-04-02T00:00:00.000Z
antibioticsdrug resistancepharma
The $150 Billion Weight Loss Industry Is Being Disrupted by GLP-1 Drugs Business
2026-04-01T17:07:23.679Z · Src: 2026-04-02T00:00:00.000Z
weight lossglp 1wegovy
The $70 Billion GLP-1 Drug Revolution: Ozempic and Wegovy Transform Healthcare Science
2026-04-01T17:00:46.424Z · Src: 2026-04-02T00:00:00.000Z
glp 1ozempicwegovy
The Antibiotic Resistance Apocalypse: 10 Million Deaths Per Year by 2050 Science
2026-04-01T15:56:16.346Z · Src: 2026-04-01T00:00:00.000Z
antibioticsantimicrobial resistsuperbugs
The $70 Billion Weight Loss Drug Revolution: GLP-1 Agonists Change Everything Science
2026-04-01T12:52:34.994Z · Src: 2026-04-01T00:00:00.000Z
glp 1ozempicwegovy
How mRNA Technology Could Cure Cancer, HIV, and Rare Diseases Science
2026-04-01T12:49:27.362Z · Src: 2026-04-01T00:00:00.000Z
mrnacancermoderna